Paper33567282
Dynamic adoption of anergy by antigen-exhausted CD4+ T cells.
Trefzer A and 12 others. Cell Rep, 2021. Cited by 41 papers, by iCite.
Cite this record
ConductScience Library. Dynamic adoption of anergy by antigen-exhausted CD4+ T cells. Papers, record 33567282. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33567282
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antigens | Major topic |
| Calcium Signaling | Major topic |
| Clonal Anergy | Major topic |
| Gene Expression Regulation | Major topic |
| MAP Kinase Signaling System | Major topic |
| Th1 Cells | Major topic |
| Animals | |
| B-Lymphocytes | |
| Female | |
| Gene Expression Profiling | |
| Mechanistic Target of Rapamycin Complex 1 | |
| Mice | |
| Mice, Transgenic | |
| Receptors, Antigen, T-Cell |
Source PubMed
Cited by32
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 41 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42960354 | From Dysfunction to Differentiation: A New Paradigm of T Cell Exhaustion. | Acta Naturae | 2026 | https://conductscience.org/library/papers/42960354 | PubMed |
| 41910264 | Non-suppressible HIV viremia sustained by clonally expanded CD4+ T cells harboring a genomically defective provirus with an immune-evasive protein expression profile. | mBio | 2026 | https://conductscience.org/library/papers/41910264 | PubMed |
| 41799779 | A prognostic 19-gene signature and LBP-mediated immune dysregulation define the tumor microenvironment in poor-prognosis KIRC. | Int J Med Sci | 2026 | https://conductscience.org/library/papers/41799779 | PubMed |
| 41751962 | Do Metastatic Cells Arise from PD-L1+ Cell Niches in Gastric Adenocarcinoma? | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/41751962 | PubMed |
| 41531737 | CCL20-CCR6 signaling alters the metabolic reprogramming to promote the pathogenic Th17 cell differentiation. | iScience | 2026 | https://conductscience.org/library/papers/41531737 | PubMed |
| 41196654 | Flt3L-Derived Antigen-Presenting Cell Transfer in Neonatal NOD Mice Reduces the Incidence of Type 1 Diabetes. | Diabetes | 2026 | https://conductscience.org/library/papers/41196654 | PubMed |
| 41034589 | Efferocytic remodelling of pancreatic islet macrophages by limited β-cell death. | Nature | 2025 | https://conductscience.org/library/papers/41034589 | PubMed |
| 41034190 | Multiple sclerosis: molecular pathogenesis and therapeutic intervention. | Signal Transduct Target Ther | 2025 | https://conductscience.org/library/papers/41034190 | PubMed |
| 40726062 | Aging and Viral Evolution Impair Immunity Against Dominant Pan-Coronavirus-Reactive T Cell Epitope. | Eur J Immunol | 2025 | https://conductscience.org/library/papers/40726062 | PubMed |
| 40707326 | Cell-intrinsic CD4 T cell tolerance: a new frontier in therapy? | Trends Immunol | 2025 | https://conductscience.org/library/papers/40707326 | PubMed |
| 40672265 | Resolving ScRNA-Seq Signatures of Antigen-Specific CD4+ T Cells in Tolerance across Semi-Allogeneic Transplantation and Pregnancy. | bioRxiv | 2025 | https://conductscience.org/library/papers/40672265 | PubMed |
| 40450686 | Ocular immune privilege in action: The living eye imposes unique regulatory and anergic gene signatures on uveitogenic T cells. | Cell Rep | 2025 | https://conductscience.org/library/papers/40450686 | PubMed |
| 40236693 | Deciphering T-cell exhaustion in the tumor microenvironment: paving the way for innovative solid tumor therapies. | Front Immunol | 2025 | https://conductscience.org/library/papers/40236693 | PubMed |
| 40165970 | Nanoparticle platform preferentially targeting liver sinusoidal endothelial cells induces tolerance in CD4+ T cell-mediated disease models. | Front Immunol | 2025 | https://conductscience.org/library/papers/40165970 | PubMed |
| 40133260 | Kinetically activating nanovaccine mimicking multidimensional immunomodulation of natural infection for broad protection against heterologous viruses in animal models. | Nat Commun | 2025 | https://conductscience.org/library/papers/40133260 | PubMed |
| 39589811 | Endogenous antigens shape the transcriptome and TCR repertoire in an autoimmune arthritis model. | J Clin Invest | 2024 | https://conductscience.org/library/papers/39589811 | PubMed |
| 39214091 | CD4+ T cells reactive to a hybrid peptide from insulin-chromogranin A adopt a distinct effector fate and are pathogenic in autoimmune diabetes. | Immunity | 2024 | https://conductscience.org/library/papers/39214091 | PubMed |
| 38319998 | Cbl-b mitigates the responsiveness of naive CD8+ T cells that experience extensive tonic T cell receptor signaling. | Sci Signal | 2024 | https://conductscience.org/library/papers/38319998 | PubMed |
| 38086932 | Therapeutic induction of antigen-specific immune tolerance. | Nat Rev Immunol | 2024 | https://conductscience.org/library/papers/38086932 | PubMed |
| 37862030 | BATF represses BIM to sustain tolerant T cells in the periphery. | J Exp Med | 2023 | https://conductscience.org/library/papers/37862030 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/33567282
GET https://conductscience.org/api/papers/v1/33567282/cited_by?page=2